Citeline：2026版已完成临床试验年报（英文版）

Trialtrove recorded 4,364 industry-sponsored clinical studies from Phase I through Phase III/IV that either reached completed status or attained primary endpoints during 2025. This is an 11% decrease from the previous year, which reported 4,903 completed trials. An additional1,002 trials were noted as terminated in 2025, which is a 13% decrease from 2024 (1,153).1 After the last two years of consecutive gains seen for completed studies across every therapeutic area (TA), this year’s resultsla